Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Observational × Trastuzumab × Clear all

Status

Completed 17 Unknown 10 Active not recruiting 4 Terminated 2 Suspended 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 2 Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Specimen Handling 3 osimertinib 1 Trastuzumab 1 Tomography, Optical Coherence 1 Surveys and Questionnaires 1 Phlebotomy 1 Phenotype 1 Palliative Care 1 Microscopy, Confocal 1 Mental Status and Dementia Tests 1 Magnetic Resonance Spectroscopy 1 Immune Checkpoint Inhibitors 1 High-Energy Shock Waves 1 Health Care Economics and Organizations 1 Genetic Testing 1 Biomarkers 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02062983 2016-05-13

Early Predictor of Herceptin Cardio Toxicity in Breast Cancer Patients

National Guard Health Affairs

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡